Mucosal immunity against SARS-CoV-2 variants of concern including Omicron following vaccination is a research paper published in medRxiv (2022). On theSindex it has a DataRank of 0.208. It has been cited 3 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.208
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →National Institutes of Health
Grant: 1R01AG047156-01A1
Simultaneously boosting both humoral and cellular immunity following vaccination
National Institutes of Health
Grant: 3U54CA260582-02S3
Center for serological testing to improve outcomes from pandemic COVID-19 (STOP-COVID)
National Institutes of Health
Grant: 2R01AI147394-06
Host cellular network governing the development of post SARS-CoV-2 tissue sequelae
National Institutes of Health
Grant: 1R01AG069264-01
Elucidating the roles of alveolar macrophage inflammation and selfrenewal during influenza infection
National Institutes of Health
Grant: 5R01AI150473-04
TIM-mediated Inhibition of HIV Release: Cooperation with SERINC and Antagonism by Nef
Fields of Study
Keywords
Sustainable Development Goals